ArticleJournal of cellular and molecular medicine2023

Ribosomal protein L22-like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway.

Xiaoyu Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.